Samuel Vasikaran, MD, FRCPA, is a Consultant Chemical Pathologist at PathWest –Laboratory Medicine, Western Australia. He has a special interest and expertise in bone turnover markers, with over 130 peer reviewed publications and book chapters. Dr Vasikaran chaired the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Working Group on Bone Marker Standards which, in collaboration with the International Osteoporosis Foundation, designated serum PINP and CTX as the reference bone turnover markers in osteoporosis. He is currently member of the IFCC Committee on Bone Metabolism.
Scientific Shorts